Aegon shareholders have approved the company's plan to redomicile in the US, clearing the main hurdle for the Dutch-founded group to reincorporate in Delaware and rebrand as Transamerica Inc.
At an extraordinary general meeting, shareholders backed the redomiciliation and an omnibus incentive plan. That gives Aegon the mandate to move its legal seat from Bermuda to Delaware and its head office from the Netherlands to New York.
Aegon said it expects to repurchase all Common Shares B held by its largest shareholder, Vereniging Aegon, on October 15, in exchange for common shares with equal voting rights on a 40-to-1 basis. Interim bye-laws approved at the meeting will take effect at that point. Vereniging Aegon will be renamed Vereniging Aegon Americas and will keep a stake of about 18.4%. Its charitable activities in the Netherlands will continue through a newly established foundation, Stichting Aegon Fonds Nederland.
The company first announced the plan at its Capital Markets Day in December 2025, describing it as a way to sharpen its focus on the US life insurance and retirement market. According to Aegon’s shareholder materials, Transamerica accounts for about 80% of its operations.
Under the plan, Aegon will continue into Transamerica Inc. as a Delaware corporation, keeping its legal personality and converting its existing common shares into Transamerica stock. The New York Stock Exchange is expected to become the primary listing, with a listing retained on Euronext Amsterdam for the time being, and the shares are expected to trade under the symbol “TA.”
Aegon also plans to become a US tax resident and to switch from IFRS to US GAAP reporting, with its final IFRS period in the first half of 2027 and US GAAP reporting starting with full-year 2027 results. It has said the transition should be completed by January 2028.
In June, Aegon chose New York City for its corporate headquarters and announced leadership changes to support the move. Chief executive Lard Friese will relocate to the US at the beginning of 2027.
The move will change how the group is regulated. Aegon has said the lead and scope of group supervision will be reassessed by the relevant regulators at the time of the redomiciliation. It has also said it will move from a consolidated solvency view to entity-based capital ratios and ratings, the approach US insurers typically use.
For producers and distributors placing Transamerica’s life, annuity and retirement products, day-to-day business should continue unchanged. The insurance companies and policies themselves are not affected by the holding company’s change of domicile.
The longer-term effect may be strategic. A US-domiciled, US-listed parent named Transamerica will be judged by investors against US peers, and its capital and growth decisions will focus more heavily on the US market. Distributors may see that reflected in product development and in investment in the US distribution channels where Transamerica competes.
The move from group solvency to entity-based capital and ratings is also worth watching. Agents and advisors who rely on carrier financial strength when recommending products should keep an eye on how rating agencies assess Transamerica’s operating companies after the transition.
